Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . iv IVD Medical Holding Limited 華 檢 醫療 控股 有限公司 ( Incorporated in the Cayman Islands with limited liability ) ( Stock Code : 1931 ) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021 FINANCIAL HIGHLIGHTS The board ( the " Board " ) of directors ( the “ Directors ” , each a “ Director ” ) of IVD Medical Holding Limited ( the “ Company ” ) hereby announces the unaudited consolidated interim results of the Company and its subsidiaries ( hereinafter collectively referred to as the “ Group ” ) for the six months ended 30 June 2021 ( the " Reporting Period ” ) , which have been reviewed by the Company's audit committee ( the “ Audit Committee ” ) and have been approved by the Board on 20 August 2021. The financial highlights of the Group during the Reporting Period together with the comparative figures for the corresponding previous period are set out as follows : Six months ended 30 June 2021 RMB'000 ( Unaudited ) 2020 RMB'000 ( Unaudited ) Change Revenue Gross profit 1,186,791 981,240 20.9 % 239,889 194,179 23.5 % Profit for the period 77,361 36,092 114.3 % Profit attributable to owners of the parent 78,887 38,281 106.1 % Adjusted profit for the period ( Note ) 90,683 61,674 47.0 % Adjusted profit attributable to owners of the parent ( Note ) 92,209 63,863 44.4 % Earnings per share Basic ( RMB cents ) 5.96 2.87 3.09 Diluted ( RMB cents ) 5.88 2.86 3.02 Adjusted basic earnings per share ( RMB cents ) 6.97 4.79 2.18 1